| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.867 | 32.443 | 27.877 | 12.928 | 29.999 | 22.019 | 25.691 | 53.036 | 37.991 |
| Total Income - EUR | - | 6.933 | 32.444 | 28.181 | 13.304 | 30.557 | 22.344 | 26.910 | 53.036 | 37.991 |
| Total Expenses - EUR | - | 4.687 | 9.033 | 10.499 | 13.640 | 7.774 | 6.029 | 6.458 | 26.029 | 23.686 |
| Gross Profit/Loss - EUR | - | 2.246 | 23.411 | 17.682 | -336 | 22.782 | 16.316 | 20.452 | 27.007 | 14.306 |
| Net Profit/Loss - EUR | - | 2.040 | 22.438 | 16.843 | -727 | 21.936 | 15.734 | 19.849 | 26.541 | 13.983 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Jugapharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 5.422 | 22.963 | 29.117 | 22.637 | 26.797 | 31.550 | 22.779 | 34.120 | 42.679 |
| Inventories | - | 0 | 0 | 0 | 0 | 45 | 57 | 71 | 66 | 68 |
| Receivables | - | 3.203 | 19.919 | 592 | 319 | 0 | 9.776 | 13.217 | 0 | 0 |
| Cash | - | 2.220 | 3.044 | 28.526 | 22.318 | 26.752 | 21.718 | 9.492 | 34.055 | 42.610 |
| Shareholders Funds | - | 2.151 | 22.547 | 28.790 | 16.463 | 26.553 | 29.698 | 19.951 | 29.569 | 39.735 |
| Social Capital | - | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | - | 3.271 | 416 | 327 | 147 | 244 | 1.852 | 2.829 | 4.551 | 2.943 |
| Income in Advance | - | 0 | 0 | 0 | 6.027 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Jugapharm Srl